Lawmakers, Health Groups Resist Their States’ Rural Health Fund Plans
In the final days of 2025, governors around the country trumpeted the hundreds of millions…
Lawmakers, Health Groups Resist Their States’ Rural Health Fund Plans
In the final days of 2025, governors around the country trumpeted the hundreds of millions of federal dollars they won from a new, $50 billion rural health fund. But plans to spend those nine-digit awards aren’t all warmly received. At least one group of Republican state lawmakers appears to have scuttled an initiative preapproved by…
Despite Their Successes, Some Mobile Crisis Response Teams Are in Crisis
It was a snowy afternoon in Bozeman, a city of nearly 60,000 nestled among the mountains of southern Montana. Temperatures hovered in the mid-30s. The city’s mobile crisis team had just gotten a call about a man walking around outside without shoes. The man’s family told the team he was having a mental health crisis…
Real world experience with insurers pushing back on copay cards
As reported by Kaiser Health News: The value of drugmakers’ copay cards has become more unpredictable as insurers try to restrict their use. Many insurance plans, for instance, do not count the money from a copay program toward a patient’s deductible.And patients who use a copay card can wind up paying full or nearly full price…
Oren Nissim, Brook-ai – Figuring out RPM
Oren Nissim is the CEO of Brook-ai which is been making some waves in the remote care space. Their goals is to use remote patient monitoring to help providers reduce readmissions, and help patients stay on their care plans. For example they get more then 50% of their populations into hypertension control within 10 weeks,…
Grow Therapy Raises $150M to Expand Employer, Health System Partnerships
Grow Therapy’s Series D funding was led by TCV and Growth Equity at Goldman Sachs Alternatives, with participation from BCI, Menlo Ventures, Sequoia, SignalFire and Transformation Capital. The post Grow Therapy Raises $150M to Expand Employer, Health System Partnerships appeared first on MedCity News.
Theravance Drug Fails Another Pivotal Test, This Time Sparking Restructuring That Ends R&D
Ampreloxetine’s Phase 3 failure in multiple system atrophy is the third disappointing clinical trial outcome for the Theravance Biopharma drug. The biotech will now wind down all R&D and explore options that could include the sale of the company. The post Theravance Drug Fails Another Pivotal Test, This Time Sparking Restructuring That Ends R&D appeared…
Why Trump’s ‘Cash for Healthcare’ Idea Likely Wouldn’t Work in Practice
Last week, Trump proposed cutting out insurers and giving Americans cash to buy their own healthcare, claiming it would lower costs. Ali Diab, an economist and CEO of Collective Health, said the plan overlooks the real problem: concentrated payer power, opaque pricing and the financial risk people face without insurance. The post Why Trump’s ‘Cash…
The Global HIV/AIDS Epidemic
This updated fact sheet provides the latest data on the global HIV/AIDS epidemic, including impact on affected and vulnerable populations, treatment and prevention efforts, and an overview of the U.S. and global responses to the epidemic.
Analyzing Changes in Medicare Part D Enrollment for 2026
The Medicare Part D prescription drug benefit is provided by private plans, either Medicare Advantage plans that offer drug coverage (MA-PDs) or, for those in traditional Medicare, stand-alone prescription drug plans (PDPs). New data from CMS shows that 56 million people are enrolled in Part D plans as of February 2026, with more in MA-PDs…
How New Medicare Rules Will Reshape Cardiac Monitoring and Remote Patient Care
For providers, the rules mean more control over monitoring and the chance to keep a larger share of reimbursement. For device companies, they create a chance to show measurable value and guide clinicians through a system that is shifting quickly. The post How New Medicare Rules Will Reshape Cardiac Monitoring and Remote Patient Care appeared…
